CRISPR Therapeutics (CRSP) Earnings Date, Estimates & Call Transcripts → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free crsp Stock Alerts $56.41 +0.75 (+1.35%) (As of 04:00 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 13EstimatedActual EPS (Feb. 21) $1.10 Beat By $0.95 Consensus EPS (Feb. 21) $0.15 Get CRISPR Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CRSP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCRSP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRSP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> CRISPR Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244($1.98)($1.19)($1.59)Q2 20244($2.24)($1.13)($1.64)Q3 20244($1.78)($1.12)($1.47)Q4 20244($2.01)($0.80)($1.44)FY 202416($8.01)($4.24)($6.13)Q1 20252($1.73)($1.50)($1.62)Q2 20252($2.26)($1.37)($1.82)Q3 20252($1.36)($1.25)($1.31)Q4 20252($1.66)($1.14)($1.40)FY 20258($7.01)($5.26)($6.14)CRSP Earnings Date and InformationCRISPR Therapeutics last announced its earnings results on February 21st, 2024. The reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.95. The company had revenue of $201.20 million for the quarter, compared to the consensus estimate of $148.72 million. Its revenue was up 3253.3% on a year-over-year basis. CRISPR Therapeutics has generated ($1.96) earnings per share over the last year (($1.96) diluted earnings per share). Earnings for CRISPR Therapeutics are expected to grow in the coming year, from ($6.24) to ($4.39) per share. CRISPR Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.Read More CRISPR Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Estimated)------- 2/21/2024Q4 2023$0.15$1.10+$0.95$1.10$148.72 million$201.20 million11/6/2023Q3 2023($2.04)($1.41)+$0.63($1.41)$5.05 million-8/7/2023Q2 2023($2.13)($0.98)+$1.15($0.98)$1.80 million$70.00 million5/8/2023Q1 2023($1.64)($0.67)+$0.97($0.67)$24.33 million$100.00 million 2/21/2023Q4 2022($2.27)($1.41)+$0.86($1.41)$7.37 million$6.00 million 11/1/2022Q3 2022($2.30)($2.24)+$0.06($2.24)$3.53 million$0.09 million Get the Latest News and Ratings for CRSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($2.23)($2.40)($0.17)($2.40)$2.20 million$0.20 million5/9/2022Q1 2022($1.91)($2.32)($0.41)($2.32)$2.45 million$0.94 million2/14/2022Q4 2021($1.74)($1.84)($0.10)($1.84)$5.39 million$12.90 million 11/3/2021Q3 2021($1.75)($1.67)+$0.08($1.67)$3.85 million$0.82 million7/29/2021Q2 2021$3.52$9.44+$5.92$9.44$678.05 million$900.70 million4/26/2021Q1 2021($1.47)($1.51)($0.04)($1.51)$4.99 million$0.54 million CRISPR Therapeutics Earnings - Frequently Asked Questions When is CRISPR Therapeutics's earnings date? CRISPR Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on CRSP's earnings history. Did CRISPR Therapeutics beat their earnings estimates last quarter? In the previous quarter, CRISPR Therapeutics (NASDAQ:CRSP) reported $1.10 earnings per share (EPS) to beat the analysts' consensus estimate of $0.15 by $0.95. Learn more on analysts' earnings estimate vs. CRSP's actual earnings. How much revenue does CRISPR Therapeutics generate each year? CRISPR Therapeutics (NASDAQ:CRSP) has a recorded annual revenue of $371.21 million. How much profit does CRISPR Therapeutics generate each year? CRISPR Therapeutics (NASDAQ:CRSP) has a recorded net income of -$153.61 million. CRSP has generated -$1.96 earnings per share over the last four quarters. What is CRISPR Therapeutics's EPS forecast for next year? CRISPR Therapeutics's earnings are expected to grow from ($6.24) per share to ($4.39) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Halozyme Therapeutics Earnings Date Krystal Biotech Earnings Date Immunovant Earnings Date Revolution Medicines Earnings Date ImmunityBio Earnings Date Iovance Biotherapeutics Earnings Date SpringWorks Therapeutics Earnings Date Vaxcyte Earnings Date Apogee Therapeutics Earnings Date Arcellx Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:CRSP) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.